期刊文献+

肺神经内分泌肿瘤患者预后影响因素分析

Factors influencing the prognosis in patients with pulmonary neuroendocrine tumors
原文传递
导出
摘要 目的探讨影响肺神经内分泌肿瘤患者预后的因素。方法回顾性分析2001年12月至2013年12月间福建省肿瘤医院收治的71例肺神经内分泌肿瘤患者的临床资料,其中,资料完整患者54例。使用COX单因素和多因素回归分析法,探讨患者临床治疗特征和治疗方法对生存期的影响。结果单因素分析显示年龄、肿瘤分期、淋巴转移情况、组织学类型和治疗方法是影响患者预后的因素。多因素分析显示淋巴转移、肿瘤分期和治疗方法是影响患者生存期的独立因素。结论手术治疗是肺神经内分泌肿瘤患者首选治疗方式,但淋巴转移和肿瘤分期会影响患者生存期。 Objective To explore the factors that influence the prognosis of pulmonary neuroendo- crine tumors. Methods A retrospective analysis of 71 patients with pulmonary neuroendoerine tumors trea- ted at Fujian Provincial Cancer Hospital from December 2001 to December 2013 were conducted. Among them, 54 patients had complete data. Using Cox univariate and multivariate regression analysis, the effect of theraputic features and strategies on survival was discussed. Results Univariate analysis showed that age, tumor stages, lymph node metastasis, histological type and treatment regimens were factors influencing the prognosis. Multivariate analysis showed that lymph node metastasis, tumor stages and treatment regimens were independent factors influencing the survival. Conclusion Surgery is the preferred therapy for pulmo- nary neuroendocrine tumors but the lymph node metastasis and tumor stages have an effect on the survival.
出处 《中国肿瘤临床与康复》 2017年第7期781-783,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 肺神经内分泌肿瘤 预后 影响因素 Pulmonary neuroendoerine neoplasms Prognosis Influencing factors
  • 相关文献

参考文献1

二级参考文献19

  • 1时广利,胡秀玲,岳思东,宋长兴.血清肿瘤标志物在肺癌辅助诊断中的应用[J].中华肿瘤杂志,2005,27(5):299-301. 被引量:82
  • 2Fernandez FG,Battafarano RJ.Large-Cell Neuroendocrine Carci-noma of the Lung:An Aggressive Neuroendocrine Lung Cancer[J].Cancer Control,2006,13(4):270-275.
  • 3Hage R,Seldenrijk K,de Bruin P,et al.Pulmonary large-cellneuroendocrine carcinoma(LCNEC)[J].Eur J CardiothoracSurg,2003,23(4):457-460.
  • 4Travis WD,Linnoila RI,Tsokos MG,et a1.NeuroendocrIno tumorsof the lung with proposed criteria for large-cell neuroendocrinecarcinoma.An ultrastructural,immunohistochemical and flow cy-tometric studY of 35 cases[J].Am J Surg Pathol,1991,15(6):529-553.
  • 5Brambilla E,Travis WD,Colby T,et al.The new World HealthOrganization classification of lung tumours[J].Eur Respir J.2001,18(6):1059-1068.
  • 6Paci M,Cavazza A,Annessi V,et al.Large Cell Neuroendo-crine Carcinoma of the Lung:A 10 Year Clinicopathologic Retro-spective Study[J].Ann Thorac Surg.2004,77(4):1163-1167.
  • 7Iyoda A,Hiroshima K,Toyozaki T,et al.Clinical characteriza-tion of pulmonary large cell neuroendocrine carcinoma and largecell carcinoma with neuroendocrine morphology[J].Cancer.2001,91(11):1992-2000.
  • 8Takei H,Asamura H,Maeshima A,et al.Large cell neuroendo-crine carcinoma of the lung:a clinicopathologic study of eighty-seven cases[J].J Thorac Cardiovasc Surg,2002,124(2):285-292.
  • 9Travis WD,Brambilla E,Muller-Hermelink HK,et al.WorldHealth Organization classification of tumours.pathology and ge-netics of tumours of the lung,pleura,thymus and heart[J].Ly-on:IARC Press,2004,9-124.
  • 10Takei H,Asamura H,Maeshima A,et al.Large cell neuroendo-crine carcinoma of the lung:A clinicopathologic study of eighty-seven cases[J].J Thorac Cardiovasc Surg,2002,124(2):285-292.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部